Table 2.
Variables | Univariate analysis | Multivariate analysisa | ||
---|---|---|---|---|
Coefficient | P value | Coefficient | P value | |
Visfatin | −0.361 | <0.001 | −0.331 | <0.001 |
Baseline GFR | −0.179 | 0.011 | −0.234 | 0.001 |
Flow-mediated dilatation (FMD) | 0.175 | 0.013 | 0.163 | 0.015 |
Systolic blood pressure | −0.162 | 0.022 | −0.134 | 0.051 |
Fasting blood glucose | −0.149 | 0.035 | −0.160 | 0.015 |
hsCRP level | −0.128 | 0.071 | −0.060 | 0.365 |
LDL-cholesterol level | −0.103 | 0.143 | ||
Framingham risk score (%) | −0.093 | 0.191 | ||
Age | −0.090 | 0.204 | ||
Triglyceride level | −0.073 | 0.302 | ||
Uric acid level | −0.034 | 0.626 | ||
Body mass index | 0.033 | 0.641 |
Abbreviations: eGFR, estimated glomerular filtration rate; CKD-EPI equation, Chronic Kidney Disease Epidemiology equation; hsCRP, high-sensitivity C-reactive protein; Framingham risk score included parameters with age, gender, total cholesterol, high-density lipoprotein, smoking, and systolic blood pressure; LDL, low-density lipoprotein.
aThe multivariate regression model included all available variables with P value < 0.100 in the univariate analysis.